Second-line treatment with lesinurad and allopurinol versus febuxostat for management of hyperuricemia: a cost-effectiveness analysis for Spanish patients

  1. Presa, M.
  2. Pérez-Ruiz, F.
  3. Oyagüez, I.
Revue:
Clinical Rheumatology

ISSN: 1434-9949 0770-3198

Année de publication: 2019

Volumen: 38

Número: 12

Pages: 3521-3528

Type: Article

DOI: 10.1007/S10067-019-04739-3 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable